#june vs a3 | Explore Tumblr Posts and Blogs

shinwhoohoo · 3 years

Note

Have you noticed that people are a lot less harsh towards Baro than they are Jinyoung regarding the split? Why do you think this is? Maybe since Jinyoung was the leader ?

Yup, it’s definitely something a lot of us seem to feel. If you wanna waste 15 minutes of your time, you can read my ‘Contract Megapost’ where I literally rant about everything and anything related to the split, though if not (which I’d perfectly understand lmao it’s a LOT) here’s a part I address some thoughts on Baro vs. Jinyoung leaving:

...To take it a step further in my thoughts, I’d also have to be honest and say time has not been as kind to Jinyoung for me as it has been to Baro. By this I mean, initially I felt equally supportive of them both, and respectful in their decisions and paths they chose. While I still respect their choices, and understand full well that they had every right to choose what they did, I suppose my support now, particularly for Jinyoung, has started to falter. I guess the reasons that I felt Baro may have left (i.e., sick of being an idol), seem to coincide with his choice to sign with a non-idol, acting company. Jinyoung’s reasons… don’t seem quite to fit as much. At this point, it seems that he just wanted the power and control that starting and heading a new company would bring. He wants to be able to create the music he wants, without having to necessarily confer with four other members and staff, plus the ability to choose what acting projects he wants, when he wants them. Is it a bit selfish? Yeah, if I’m being honest, I do feel that it is. There was a good possibility he could have haggled with WM enough to be given what he wanted instead of just leaving. But again, he fulfilled the duties he had under his contract with WM, so it is his every right to do what he wants, even if it comes off as transparent.

I think this ‘transparency’ is where my main issues with Jinyoung come in. With every post of his or LINK8′s, every video, every ‘#wewillnotstaysilent’, I just find myself reading right through it. Their motives seem to be very obvious, in wanting to make sure they make it known that they are pushing Jinyoung every single day as much as they can, e.g., giving him the fanmeet very soon after he officially left WM, making him a Season’s Greetings, all the acting gigs he’s been a part of in the few short months they started, the whole ‘J.GROUND’… It’s A LOT. Almost so much, that it can come across as a bit competitive towards WM and A3 in what they post and do. While I hope this isn’t the case as this would just eventually cause more of a divide, there has yet to be any reaching out between the two parties to placate any thoughts over this.

One last point I’d like to make towards Jinyoung and LINK8 is that companies just don’t sprout up (excuse the BANA pun) overnight. Jinyoung didn’t decide to finally leave WM in June, and in the span of a week (or however short of time it was before it was announced he ‘joined’ LINK8) create this new company; he had to have been putting this in the works for months, if not the better part of a year prior to leaving WM. He had to find staff to work with, find a building, create a whole image/vibe he was going for, create and file the name and logo… and a lot more. Even giving him the benefit of the doubt that people approached him, he still would have been involved in getting LINK8 off the ground for quite some time. And, pairing this with the likely idea that he hadn’t told the other members? …Imagine not only find out your leader has decided to leave the company, but has also been putting all his time and resources into creating this entirely new company behind the scenes instead of working to try and keep B1A4 together. I can only speak for myself but shit, I’d be hurt. Again, it is a striking contrast to Baro, who just cleanly left and joined an already established company (whom had likely just approached him around the time of contract negotiations)...

And like I said above, a lot of us just seem to hold this general feeling? I’ve gotten quite a few asks since the split from others about their feelings towards Baro vs. Jinyoung, and the differing harshness in particular, if you want to here what other fans feel too:

[x] [x] [x] [x] [x] [x] [x] [x] [x] [x] [x] [x] [x] ... yeah I’ll stop there 😅 😅

#that's literally only like 2% of the asks about this i didn't even realIZE how many there actually are looking back through my tags lol #b1a4 #baro #jinyoung #text #ask #reply

10 notes · View notes

snkmerchandise · 5 years

Photo

youtube

News: Figurama Collectors Armored Titan vs. Rogue Titan Elite Exclusive Statue

Preorder Start Date: June 15th, 2019 at 11pm JST Original Release Date: Last quarter of 2020 Retail Price: $1,410 USD (10-month payment plan available) Note: LIMITED TO 850 PIECES WORLDWIDE

Figurama Collectors previewed their incredible Armored Titan vs. Rogue Titan Elite Exclusive Statue at this weekend’s Wonder Festival in Japan! The figure depicts the climax of the Clash of the Titans arc, and the sculpt also includes Mikasa flying over the Titans via 3DMG.

Update (May 28th, 2019): New images and details on the statue have been released!

Figurama Collectors have announced preorder start date, release date, pricing, and more for this upcoming figure! Only 850 will be manufactured for a limited run.

The statue will stand at 61.1 cm (24 inches) tall and on a 73.4 cm (29 inches) wide base with a detailed environment design, approximately a 1/3 scale. Buyers will also receive an exclusive A3-size art print and a certificate of authenticity signed by Figurama Collectors CEO Shanab and sculptor Caleb Nefzen.

The team behind the statue are as follows:

Creative Director: Shanab, Figurama Collectors Development Team

Concept Artist: Jarold Sng

3D Artist/Sculptor: Caleb Nefzen

Coloring Artist: Mikiya Takahasi “Hellpainter”

For the next 18 days leading up to the preorder start date, Figurama Collectors will be holding a “TITANIC COUNTDOWN” on its Facebook Group, with special statue highlights, giveaways, and other content! You can also follow FC on Twitter for other general updates.

Update (June 4th, 2019): The statue’s making-of video, featuring interviews with the creators, has been published!

Update (June 14th, 2019): Preorders for the statue has officially begun at this link! As a special offer from Figurama Collectors, readers of @snkmerchandise and @snknews can use the coupon code “SNKNEWS” to get $35 off your preorder!

#snk news #armored titan #rogue titan #mikasa ackerman #reiner braun #eren yeager #wonder festival #figures #figurama collectors #news #videos

800 notes · View notes

moonlight404-translates · 10 months

Note

Hey, same person who told you which A3! VAs can rap, again.

1st, the new A3! B-day cards involving the charas playing their side roles is interesting. But I want to point out that Tenma’s WONDER RUSH chara name being Rio IS A PURE COINCIDENCE.

2nd, I just figured out which classic literature/performing work the current BLACKSTAR June Bride event songs are based on which are a fictional account on “Joan d’Arc”(it might be “The Maid of Orleans” by either Schiller or Tchaikovsky) for “aka,aka” sung by kradness & the 1925 book “Metropolis” by Thea Von Harbou for “Must be the Heart” sung by Shakemii. Also, I love all the cards for this event, especially Kei’s, Maica’s, Hari’s, Kasumi’s, Lico’s, Mokuren’s, Ginsei’s, & Gui’s (Menou’s & Zakuro’s are still good, too). Though I couldn’t believe this is the 1st BLACKSTAR June Bride event where nobody from TeamW is participating(1st event-the Top Performers of each team performed to a play based on “The Tale of the Bamboo Cutter” w/ some elements of “Swan Lake” & “Giselle”; 2nd event- TeamP(w/Ginsei) & TeamW performed based on historical events; 3rd event- a TeamK(w/ TeamP’s support) vs. TeamW(w/ TeamC’s support) event where their songs are based on the “Blood Wedding” play).

More importantly, I just want to know what is your opinion on the latest 4 songs from Paradox Live.

Hello! Yeah, I love the new BD set theme. June set got the roles I wanted, so I pulled all I had... and only got Tenma. Actually, it's funny how my gacha results are exactly the same as when I pulled for them in their event banners (ーvー;)

Oh, it seems like it was a fresh change for the June Bride events. And I agree those card sets were really good! (´｡• ᵕ •｡`)

About Paralive... the songs for these rounds are soo good!! My favorite is BAE's G△L△XY∞. It's so catchy and I love its galactic-like sound, also it's so inspiring. Cozmez's was softer than I thought it would be, but I completely like it. It feels so calm and the lyrics are easy to remember. AKYR's have this familiar melody that made it attractive to me, also Reo's lines were perfect. I haven't listened to TCW's No Matter What that much, but the chorus is my favorite part.

#anon ask and talk

0 notes

amisbro · 5 years

Text

Point of View: Shining Live 1 yr later

(I considered making the “Point of View” part just “PoV” but ehh...here we are) Been a while since I have done something like this but it is that time of year when Shining Live is going to have an Anniversary and its my first full year officially with the game...this is why its being called “1 year” and not 2 so that we can get that out of the way. Yes this IS the first full year officially that I have had Shining Live installed coming up and that actually happens around the middle of the month which is always an interesting time. Its interesting because its timing is LITERALLY going to be around the following Aniversaries “Stand my Heroes” “Idolish7″ and then of course “Shining Live” To say the VERY LEAST this is going to be a brutal month for me just when it comes to mobages because the funny irony here is that I haven’t been playing really ANY of them that much right now. I think I play “Heroes” more on and off and I played i7 like 3 times But the big one (and the focus of this piece) is Shining Live...where are we nearly a year on from the time we came back to the game? There in lies the problem See when I first started playing Shining Live originally back when the game came out in English in January of 2018 (ironic when you think about when I started watching the Anime like 4 years earlier) I actually had a lot of fun with it and was enjoying it for the most part. I think I only really had one time I uninstalled it and that was brief because of the fact that DST had come up last year and I didn’t feel like playing the events at 1 AM in the morning ET. Okay that’s only a half truth...one of the other reasons I stopped playing the game at that time (and completely wiped my old account) was because at the time I had actually spent $$$ on the game which I was not proud of. Yeah at the time I had gotten one of my favorite Photos in the game (”Aqua Crystal” Camus) but after what happened I refused to keep up the account because of the fact that I didn’t like what I had done. At that time (after fighting the damn game and Google) I completely wiped out the account and eventually started over Here is the kicker about what I just said I had started the game in January but come early March I had deleted it completely. I could tell we were going to have a weird relationship When I eventually came back to the EN Server this was sometime in August and when this happened we were getting ready for what would come to find out to be the final two chapters of the main story with the last one eerily enough being on September the 11th! I had thought that in October we were going to get a new chapter but it was around then that they were making a few changes with one being the “3 pull Birthday Boxes” and the other being they were adding “Collection Events” which now meant the month was going to be hell for anyone that wanted to play every event The thing was that now you had 1 Set List event 1 Collection event And they were still going to do “Score Battles” too...matter of fact this month is #19 which makes things interesting especially with what they brought into the game earlier this year I think I was wiling to flat out give a pass to the idea of NOT having a story part for October because they were introducing the “Collection Event” and doing the update to the Birthdays...surely November would go back to normal right and they would double up? NOT QUITE! For reasons that I can’t fathom STILL the game’s final story update still remains 9/11 and the thing is that ,while I know its only a minor group of people, (including myself) that have started looking at their story passes as they go up and up and up with nothing to use them on it gets to the point of “Why Bother?” Why bother playing a game (even for the “reruns” that came up) when the company is just trying to distract you with the fact that they haven’t done a story update in almost 1 year and not explained (when they should have and no apologist can tell me otherwise) why in the God’s Name the game has not been updated as far as the story content. Oh but they DID manage one thing recently Because of an issue (which from my understanding only a small # of players got) the video ads have been disabled and they don’t know when they are going to come back...CUTE! Alright to be fair... If the ads aren’t working for one group of people and they do for another then that gives an advantage when it comes to LP hoarding later on so it DOES level the playing field in THAT respect...not in the respect of “Pay to Win vs. F2P” despite the fact that in Belgium they have discontinued ways to buy certain things because in that country they made Lootboxes illegal (NOTE: I am fully aware that there is almost nothing in SL that is considered a “Lootbox”. You MIGHT consider Gachas “gambling” but even then that is a stretch especially with the changes that were made to the Gachas recently...putting that out there) Now think about this November December January February March April May June July And now August It’s been damn near 1 year since we have had story content in the game and yet the fandom has been so trained to accept the fact that the story mode has all but been abandoned. In this time we have had Renewals for B-Project Idolish7 got a Part 4 AND had like 2 Lives (and I own one of them already) TsukiPara has had its 2nd Anniversary Oh and Stand my Heroes ,A3! and i-Chu have had Anime Projects announced along with Season 2 of Idolish7 for next year Do ya get it or nah? Like forget the fact that Shining Live has given some of the most paltry of rewards for the # of days you played the game but its just so funny to me that when you try to explain to people “This ain’t right!” They have become so conditioned to the fact that the game has issues with keeping people’s interest to the point ,and this is hysterical, where I got people on my twitter timeline that legit start showing how many story passes they have saved up because its been that damn long OR they now start making a hashtag about whenever they see a HEAVENS member pop up in the game at some point (I’m talking about when they show up on the Duet covers) You know this is funny that I am writing this because of the fact that there was a fan project or whatever you want to call it where I had been shown a link to “apply” for a position on the staff and I outright refused because honestly the fact of the matter was that I had gotten so frustrated with Shining Live that they couldn’t handle my honesty...PERIOD! No joke on tweets that the “Shining Live” twitter put out I QT’d them and let my feelings be known about the fact that they haven;t done anything for the people that don’t care about the flood of events we have and we just want to play the story (and have HEAVENS added too but I’ll take “story” at this point) and honestly it cost me a friend...oh well...pack up and move on Here is the reality and it smacks you in the face as we nearly are up to September I am going to hang around this game for as long as needed because all I want is to see when they are going to add to the story...might be announced for something in the Anniversary or it might be legitimately the 1 year anniversary (that would be creepy) but I think people deserve to hear how frustrated a person can be when you have a progression wall and you just can’t move on and its not because of your level or being out of story tickets but its because of the fact that a company is so infatuated with MONEY that they have basically said to the people that might not care about that to go dunk! Now I will say this Does this year of frustration hamper my enjoyment of UtaPri? No not really...there is a scene I saw from one of the PVs from MLKingdom that kind of Skeeved me that ,no matter how it gets explained away to me, its still creepy af and I have seen things on the a series about the “Deep Web” that made me cringe but you know how it is. I think its time that people understand that people are allowed to be frustrated ,pissed off or however they want to feel about the game. I wish more people would “get it” and understand but sometimes it feels like you are talking to a wall and that’s not fun! It just makes you miserable because trying to explain WHY you haven’t touched a game in a good long time and not being able to have a genuine conversation so you don’t walk away more pissed off than you already are is just not cool...at least playing “Mirror’s Edge” is FUN frustration and this just makes you want to pull your hair out! I’m morbidly curious about what is in store for Shining Live for 2019-2020 and here is hoping that come the time that we get to this point NEXT YEAR its a bit more of a pleasant experience My name is Amisbro...and this is my “Point of View”

#Amisbro #Point of View #Shining Live #1 year of frustration #hopefully next year is better

2 notes · View notes

your-dietician · 3 years

Text

Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update

New Post has been published on https://depression-md.com/can-fite-reports-second-quarter-2021-financial-results-provides-clinical-update/

Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended June 30, 2021.

Corporate and Clinical Development Highlights Include:

Can-Fite Entered into Development and Commercialization Agreement in $3 Billion Veterinary Osteoarthritis Market – Can-Fite entered into a development and commercialization agreement with Vetbiolix, a France-based veterinary biotech company, for the development of Piclidenoson for the treatment of osteoarthritis in companion animals including dogs and cats. Vetbiolix will have the exclusive right to Piclidenoson in the veterinary osteoarthritis market for two years, during which time Vetbiolix will conduct proof-of-concept studies and cover all associated costs. If the studies yield positive data and Vetbiolix exercises its option to obtain the license from Can-Fite, then Vetbiolix will be obligated to pay Can-Fite upfront and milestone payments, in addition to royalties on sales upon regulatory approval for veterinary use. The canine osteoarthritis market is projected to reach $3 billion by 2024.

Can-Fite Received a Notice Allowance in China for its NASH Patent – During the second quarter, Can-Fite received a Notice Allowance in China for its patent titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”. This patent, which has subsequently been issued to Can-Fite, addresses the use of the A3 Adenosine Receptor (A3AR) ligand, the target receptor for Can-Fite’s drug platform technology, to reduce liver fat particularly in patients with NASH.

Patent Filed for A3AR-based Cannabis Compounds in the Treatment of Liver Diseases – Can-Fite’s preclinical studies of cannabis compounds found CBD rich T3/C15 induced inhibition of liver cancer cell growth and also had an inhibitory effect on liver fibrosis, which is associated with NAFLD/NASH, cirrhosis, and liver cancer. Can-Fite has filed patent applications to protect its discovery of cannabinoid-based therapies where the A3AR target is overexpressed.

Phase III Psoriasis Study Nears Completion of Enrollment – The Phase III Comfort™ study completed enrollment of 75% of planned patients during the second quarter, with full enrollment expected in the coming weeks. The study is designed to establish Piclidenoson’s superiority compared to placebo and non-inferiority compared to Apremilast (Otezla®) in patients with moderate to severe plaque psoriasis. Topline results are expected Q1 2022.

Phase II COVID-19 Study Expands into Europe – Can-Fite’s ongoing Phase II study, under a U.S. FDA protocol, has been enrolling patients in Israel and expanded enrollment into Europe during the second quarter. The randomized, double blind, placebo-controlled study is evaluating the benefits of treatment with Piclidenoson plus standard supportive care (SSC) vs. placebo plus SSC in 40 patients hospitalized with moderate to severe COVID-19, as defined by the U.S. National Institutes of Health Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

Phase IIb NASH Study Receives Clearance from Israeli Ministry of Health – Can-Fite received clearance from the Israeli Ministry of Health to commence a Phase IIb study of its drug candidate Namodenoson in the treatment of NASH. Patient enrollment is expected to commence Q3 2021, ahead of the prior expected start date of Q4 2021. The Company expects to expand the study to additional clinical sites in Europe. A prior Phase IIa clinical trial of Namodenoson in the treatment of NASH met study endpoints showing anti-steatotic, anti-inflammatory, and anti-fibrotic effects.

Pivotal Phase III Liver Cancer Study Expected to Commence Q4 2021 – Can-Fite has completed preparatory work for its pivotal Phase III study and plans to submit its study protocol and plans to Institutional Review Boards (IRBs) at potential clinical sites. The double blind, placebo-controlled trial will enroll 450 patients diagnosed with HCC and underlying Child Pugh B7 (CPB7) through clinical sites worldwide. Patients will be randomized to oral treatment with either 25 mg Namodenoson or matching placebo given twice daily. The primary efficacy endpoint of the trial is overall survival.

Fortified Balance Sheet

On June 30, 2021 Can-Fite had approximately $7.5 million in cash, cash equivalents, and short-term deposits. The Company closed an additional $10 million registered direct offering in August 2021.

“We expect multiple milestones in the coming months including topline results from our Phase III psoriasis study, in addition to the commencement of our pivotal Phase III in liver cancer and Phase IIb in NASH. We believe positive topline results may lead to further expansion of our global distribution strategy which has included significant non-dilutive funding,” stated Can-Fite CEO Dr. Pnina Fishman.

Financial Results

Revenues for the six months ended June 30, 2021 were $0.39 million compared to revenues of $0.40 million during the six months ended June 30, 2020. The decrease is considered immaterial.

Research and development expenses for the six months ended June 30, 2021 were $3.81 million compared with $7.05 million for the same period in 2020. Research and development expenses for the first half of 2021 comprised primarily of expenses associated with two studies for Piclidenoson, a Phase II study in COVID-19 and a Phase III study in the treatment of psoriasis. The decrease is primarily due to costs incurred in the first six months of 2020 associated with Phase II studies for Namodenoson in the treatment of liver cancer and NASH, and a Phase III study of Piclidenoson for the treatment of rheumatoid arthritis, partially offset by the two ongoing studies of Piclidenoson in the first six months of 2021. We expect research and development expenses will increase through 2021 and beyond.

General and administrative expenses were $1.89 million for the six months ended June 30, 2021 compared to $1.45 million for the same period in 2020. The increase is primarily due to the increase in salaries and related benefits due to the distribution of bonuses to employees. We expect general and administrative expenses will remain at the same level through 2021.

Financial income, net for the six months ended June 30, 2021 was $0.20 million compared to financial expense, net of $0.12 million for the same period in 2020. The decrease in financial expense, net was mainly due to finance income recorded from revaluation of our short-term investment.

Can-Fite’s net loss for the six months ended June 30, 2021 was $5.09 million compared with a net loss of $8.23 million for the same period in 2020. The decrease in net loss was primarily attributable to a decrease in research and development expenses which were partly offset by an increase in general and administrative expenses and a decrease in finance expenses, net.

As of June 30, 2021, Can-Fite had cash, cash equivalents and short-term deposits of $7.53 million as compared to $8.26 million at December 31, 2020. The decrease in cash during the six months ended June 30, 2021 is due to an aggregate of $2.74 million in net proceeds received through warrant exercise transactions during the first quarter of 2021 and from an advance payment of $2.25 million from a distribution agreement with Ewopharma which were offset by Company’s operating activity.

The Company’s consolidated financial results for the six months ended June 30, 2021 are presented in accordance with US GAAP Reporting Standards.

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S dollars in thousands (except for share and per share data)

June 30,

December

2021

31, 2020

Unaudited

Audited

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

1,025

8,268

Short-term deposits

6,512

–

Other receivable and prepaid expenses

1,745

1,057

Short-term investment

271

Total current assets

9,553

9,400

NON-CURRENT ASSETS:

Operating lease right of use assets

Property, plant and equipment, net

Total long-term assets

127

123

Total assets

9,680

9,523

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S dollars in thousands (except for share and per share data)

June 30,

December

2021

31, 2020

Unaudited

Audited

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Trade payables

1,005

561

Current maturity of operating lease liability

Deferred revenues

1,002

334

Other accounts payable

309

331

Total current liabilities

2,359

1,269

NON-CURRENT LIABILITIES:

Long – term operating lease liability

Deferred revenues

3,341

2.156

Total long-term liabilities

3,366

2,180

CONTINGENT LIABILITIES AND COMMITMENTS

SHAREHOLDERS’ EQUITY:

Ordinary shares of NIS 0.25 par value – Authorized: 5,000,000,000 and 1,000,000,000 shares at June 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 515,746,293 shares as of June 30, 2021; 463,769,463 shares as of December 31, 2020

37,008

33,036

Additional paid-in capital

96,386

97,380

Accumulated other comprehensive income

1,127

Accumulated deficit

(130,566

)

(125,469

)

Total equity

3,955

6,074

Total liabilities and shareholders’ equity

9,680

9,523

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

U.S dollars in thousands (except for share and per share data)

Six months ended

June 30,

2021

2020

Unaudited

Revenues

398

402

Research and development expenses

(3,810

)

(7,054

)

General and administrative expenses

(1,892

)

(1,455

)

Operating loss

(5,304

)

(8,107

)

Total financial income (expenses), net

207

(128

)

Net loss

(5,097)

(8,235

)

Total comprehensive loss

(5,097

)

(8,235

)

Deemed dividend

–

(715

)

Net loss attributed to ordinary shareholders

(5,097

)

(8,950

)

Basic and diluted net loss per share

(0.01

)

(0.04

)

Weighted average number of ordinary shares used in computing basic and diluted net loss per share

500,010,114

254,940,675

About Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. The Company’s lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis and a Phase II study in the treatment of moderate COVID-19. Can-Fite’s liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. CF602, the Company’s third drug candidate, has shown efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. For more information please visit: www.can-fite.com.

Forward-Looking Statements

This press release may contain forward-looking statements, about Can-Fite’s expectations, beliefs or intentions regarding, among other things, market risks and uncertainties, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, Can-Fite or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by Can-Fite with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of Can-Fite’s authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause Can-Fite’s actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause Can-Fite’s actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all; uncertainties of cash flows and inability to meet working capital needs; the impact of the COVID-19 pandemic; the initiation, timing, progress and results of our preclinical studies, clinical trials and other product candidate development efforts; our ability to advance our product candidates into clinical trials or to successfully complete our preclinical studies or clinical trials; our receipt of regulatory approvals for our product candidates, and the timing of other regulatory filings and approvals; the clinical development, commercialization and market acceptance of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and our ability to operate our business without infringing the intellectual property rights of others; competitive companies, technologies and our industry; statements as to the impact of the political and security situation in Israel on our business; and risks and other risk factors detailed in Can-Fite’s filings with the SEC and in its periodic filings with the TASE. In addition, Can-Fite operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. Can-Fite does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise.

Source link

0 notes

anisanews · 3 years

Text

Euro 2021 third-place rules: How best 3rd-place teams advance from groups

The group stage of the 2021 Euros will see 16 of the 24 teams advance to the knockout rounds.

In addition to the top two teams in each of the six groups (12 in total), the four best third-place finishers will also qualify for the Round of 16.

To make it easy, we’ve created a separate standings table (below) for the current third-placed teams. The lucky four teams to move on are determined by the following criteria established by UEFA in this specific order:

most points

superior goal difference

most goals scored

most wins

fewest disciplinary points in group stage matches

position in the overall European Qualifiers rankings

Croatia and Spain are currently on the outside looking in with Switzerland, Portugal, Austria and Finland having currently accumulated the most points. Switzerland have played one more game than the rest of the field.

Third-Place Teams (top 4 advance)

Team Group PTS GP W L D GF GA GD 1. Switzerland A 4 3 1 1 1 4 5 -1 2. Portugal F 3 2 1 1 0 5 4 +1 3. Austria C 3 2 1 1 0 3 3 0 4. Finland B 3 2 1 1 0 1 1 0 5. Spain E 2 2 0 0 2 1 1 0 6. Croatia D 1 2 0 1 1 1 2 -1

(PTS=points, W=Wins, L=Losses, D=Draws, GF=Goals For [Scored], GA=Goals Against [Allowed], GD=Goal Difference)

Once we know the four 3rd-placed teams that will be advancing, the next step will be to figure out their opponent in the Round of 16.

UEFA has already outlined the Round of 16 matchups based on the groups from which the third-place teams hail (page 19 of tournament regulations). The predetermined permutations follow below:

Round of 16 Pairings

3rd-Place Teams vs. B1 vs. C1 vs. E1 vs. F1 A, B, C, D A3 D3 B3 C3 A, B, C, E A3 E3 B3 C3 A, B, C, F A3 F3 B3 C3 A, B, D, E D3 E3 A3 B3 A, B, D, F D3 F3 A3 B3 A, B, E, F E3 F3 B3 A3 A, C, D, E E3 D3 C3 A3 A, C, D, F F3 D3 C3 A3 A, C, E, F E3 F3 C3 A3 A, D, E, F E3 F3 D3 A3 B, C, D, E E3 D3 B3 C3 B, C, D, F F3 D3 C3 B3 B, C, E, F F3 E3 C3 B3 B, D, E, F F3 E3 D3 B3 C, D, E, F F3 E3 D3 C3

Here’s the full Round of 16 schedule with TV and streaming assignments in the USA. We’ll be slotting in the names of the teams as they clinch:

Euro 2021 – Round of 16

Date Match Time (TV channels) Stream Sat, June 26 Wales vs. B2 12 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Sat, June 26 Italy vs. C2 12 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Sun, June 27 Netherlands vs. D3/E3/F3 12 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Sun, June 27 B1 vs. A3/D3/E3/F3 3 pm ET (ABC, Univision, TUDN) fuboTV , ESPN app, ESPN3, TUDN.tv Mon, June 28 D2 vs. E2 12 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Mon, June 28 F1 vs. A3/B3/C3 3 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Tues, June 29 D1 vs. F2 12 pm ET (ESPN) fuboTV , ESPN app, PrendeTV Tues, June 29 E1 vs. A3/B3/C3/D3 3 pm ET (ESPN, Univision, TUDN) fuboTV , ESPN app, TUDN.tv

from Anisa News https://ift.tt/3gNSupp

#breaking news today breaking news headlines breaking news headlines today chicago breaking news usa

0 notes

shinwhoohoo · 6 years

Note

(1) (long ask, bear w me, sorry!) i had a dream shinwoo argued with jinyoung for taking up too much screentime in the a lie mv and that's why jy left :( I woke up convinced they ended on bad terms. i really hope they're all still bros.

(2) re: ‘traitor’ discourse, i was glad that anon put it into words. i guess my subconscious too 'blames’ jy (baro less so, despite him being the one who is apparently more eager to move on. bc my gut said he checked out (of the whole idol thing) long before they split. so him leaving, dropping his stage name feels like a logical conclusion, good for him tbh). while jy used to insist b1a4 were forever and jinx schminx etc (as recently as their anni?), but is now happy to be doing his own thing?(3) i immediately hate myself for saying that bc i really do love him and think link8 is adorable and trying very hard where wm failed. i know bayoung left wm, not b1a4, and they might not be pandering and we will actually get ot5 somewhere down the line. or j ground producing for ot3 (wow). I also never wanted/ expected 'b1a4 forever’ if that was not what they wanted.(4) i also realised, writing this, they likely each had their own different reasons for leaving (baro’s change in career goals vs jy’s issues with wm’s management): so i can’t blame one more than the other for not wanting to stick around. sorry for the rambling ask (more venting/ stream of consciousness than question lol, but i would appreciate your thoughts)

No need to apologize! If there’s anyone who understands ranting most, it’s probably me 😆 Plus, it’s always nice to hear other’s thoughts. I’ll try my best to succinctly go through all of your points you made here by paragraph:

I wonder what all their relationships are right now too. Probably is safe to say there is a ‘divide’ of some sorts between A3 and Bayoung, though it’s also likely safe to say this divide isn’t necessarily equal between all the members; i.e., CNU being the more introspective and sensitive person he is, probably feels more of a wall between Bayoung then say, Sandeul. Gongchan is probably somewhere in the middle, albeit closer to CNU’s feelings. The fact we’ve heard next to nothing from him isn’t particularly reassuring, either. Whether they all feel like ‘bros’ still or not, I guess remains to be seen. But I’m still partial to thinking that their bond is too deep for it to be cut off, and I believe in due time they all will be close (enough) again. Interesting dream though! Yeah, Jinyoung def got the spotlight in that MV 😅

Interesting how so many of you seem to share those same thoughts about Jinyoung and Baro (though it seems to different extents and towards either one or the other more)… idk, I still can’t quite get on that train. This isn’t to say that I agree with all of their choices, but I think because I just wasn’t surprised with them leaving (more so that I was surprised that the rest stayed with WM tbh) hearing that news didn’t cause such a sharp pain that is seeming to stick with the rest of you. Jinyoung to me was always the biggest go-getter of the group, so of course he’d jump at the opportunity to put his skills and talents to the test and create his own thing (company? studio? remains to be seen– hope we find out more soon). And Baro, like you said, definitely seemed over it. I wrote about it months ago at this point, of him being just done with idol life so again, him leaving was something that was super shocking. Also in the post I just linked, is where Jinyoung talks about them still having ‘lots to work on’ and yada yada about the 7 year jinx, and how it’s CNU who confesses he is worried about members leaving. Very interesting to look back on that now, from their DINGO drunk Rollin’ rendition, almost a year(!) ago. Idk if CNU was already getting hints of things shifting and changing, but he clearly felt it, whereas Jinyoung was hesitant to say anything but the normal, expected answer. I get it, it seems a bit shady tbh, to hear how Jinyoung was still spewing out ot5 forever answers and then is the one the winds up leaving, going on overdrive promoting, and even using B1A4′s tagline as his own (which obviously, I was a bit meh about that whole thing). But again, I think we really just need to give him a chance and hear him out. I really do hope that at his fanmeet, we will be given more answers from him.

Don’t feel to guilty about your feelings~! It’s understandable you are feeling this way. It’s important to try and stay realistically optimistic about it. Bayoung still consider themselves B1A4, and while we likely won’t get an ot5 soon, there are still plenty of other options that can happen down the line. I’m looking forward to it.

Agree with both of your thoughts of Baro vs Jinyoung leaving. Baro was likely wanting to just get out of the idol lifestyle, whereas Jinyoung still seems very much connected with the fans and the industry, instead just wanting his own creative freedoms. It isn’t something you can really blame them for one way or the other; at the end of the day, they’re both free to do as they please now that their contracts are up. My biggest question would be when did each come to this conclusion– for example, I feel that Baro has been pretty over it all for some time, and the last straw may have just been the rumors of his girlfriend and lovestagram & attitude controversies. Whereas with Jinyoung.. that’s an interesting case. I could see that being a much more recent development, which was why A3 seemed particularly shocked in their statements when the news initially broke out June 30th. I’d love to know– but we probably never will.

#ah shit now time to tag everything i mention lol #b1a4 #jinyoung #baro #cnu #introspective bear #sandeul #gongchan #shindeulchan #wm entertainment #link 8 entertainment #j.ground #dingo #text #ask #reply

4 notes · View notes